Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-02-22 to 2023-02-23
Current total value of award: $960.6
Description: 4560129735!ESMOLOL HYDROCHLORIDE